Dr. Mark I. Grijnsztein, MD

  • Elk Grove, CA
  • Allergist and immunologist
NPI1164580866PAC ID5698737666
Medicare services, 2024
2,502
Medicare patients, 2024
143
Part D claims, 2024
819
Hospital affiliations
1
Industry payments
$236
Practice address
8170 Laguna Blvd. Suite 112, Elk Grove, CA 95758
Practice phone
Call (916) 691-5922
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Sutter Imaging Elk Grove

Mammography / Breast Imaging Center · Elk Grove, California

See all 4 affiliations

Find Dr. Grijnsztein's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark I. Grijnsztein is an allergist and immunologist in Elk Grove, California

Dr. Grijnsztein practices at Sutter Imaging Elk Grove in Elk Grove, California.

Dr. Grijnsztein's NPI, 1164580866, was assigned on December 5, 2006. Dr. Grijnsztein graduated from Tel Aviv University Sackler in 1998. Dr. Grijnsztein holds California license A96813.

NPI and contact details
Medicare PAC ID
5698737666
NPI enumeration date
December 5, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(916) 691-5922
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
54
Medical school graduation
1998

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mark I. Grijnsztein practices at Sutter Imaging Elk Grove in Elk Grove, California

Dr. Grijnsztein's primary practice is Sutter Imaging Elk Grove, at 8170 Laguna Blvd. Suite 112, Elk Grove, CA 95758. The practice phone is (916) 691-5922.

  • Sutter Imaging Elk Grove
    8170 Laguna Blvd. Suite 112, Elk Grove, CA 95758Phone(916) 691-5922

Source: Dmand AI Affiliation Data

Dr. Mark I. Grijnsztein is affiliated with 3 sites of care and 1 medical group

Dr. Grijnsztein's primary practice is Sutter Imaging Elk Grove in Elk Grove, California. Dr. Grijnsztein is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Grijnsztein to 1 more group practice or clinic, named with a free account. Dr. Grijnsztein's employer is on file too: a breast imaging center.

See all 4 affiliations for Dr. Grijnsztein

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mark I. Grijnsztein's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grijnsztein practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Sutter Imaging Elk GroveAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Grijnsztein practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark I. Grijnsztein is one of 386 allergists and immunologists in California

Allergy and immunology is Dr. Grijnsztein's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Grijnsztein is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Grijnsztein's licenses on file in 3 states: California, New Jersey and New York.

Specialties and state licenses

  • Allergy and immunology, CaliforniaPrimaryLicense A96813 · 2006 to 2026 · taxonomy 207K00000X
  • New Jersey license2004 to 2007
  • New York license2001 to 2006

Clinical focus

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies and hives among the conditions Dr. Grijnsztein treats.

Allergists and immunologists near Dr. Grijnsztein

Counts of allergists and immunologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark I. Grijnsztein billed Medicare for 2,502 services in 2024

CMS data shows 2,502 Medicare services from Dr. Grijnsztein across 8 procedure codes in 2024, for 143 Medicare patients. Medicare paid $30,683 for them. Every service was in an office.

Medicare services, 20242,502
Medicare patients143
Paid by Medicare$30,683
Procedure codes8

Dr. Grijnsztein's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Tests and treatments
2023: 1,6582024: 2,30839%
Office and hospital visits
2023: 1482024: 19431%

Dr. Grijnsztein compared with the California median for allergists and immunologists, 2024

  • Dr. Grijnsztein
  • California median
Medicare services
2,502vs 1,84036% above
Medicare patients
143vs 145Close to median
Part D claims
685vs 2592.6 times

Medians across 368 allergists and immunologists in California with Dmand AI profiles that report each measure.

Dr. Grijnsztein's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Grijnsztein

Need commercial claims for Dr. Grijnsztein?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Grijnsztein and other allergists and immunologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mark I. Grijnsztein treated 143 Medicare patients in 2024, average age 72

CMS counts 143 Medicare patients who saw Dr. Grijnsztein in 2024. The largest group is 65 to 74, with 60 patients. 62% of them have high blood pressure, and 61% have high cholesterol. 13% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grijnsztein's median patient age at 40, with 59% women.

Medicare patients, 2024143
Average age72
Average risk score0.87
Also on Medicaid13%

Dr. Grijnsztein's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Grijnsztein's Medicare patients by sex, 2024

  • Women9667%
  • Men4733%

Chronic conditions among Dr. Grijnsztein's Medicare patients, 2024

  1. High blood pressure62%
  2. High cholesterol61%
  3. Arthritis49%
  4. Asthma39%
  5. Mood disorders22%
  6. Chronic kidney disease20%
  7. Osteoporosis19%
  8. Anxiety18%

Share of Medicare patients with each condition. A patient can have several.

Dr. Grijnsztein's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 40

Patient panel by sex, all payers

  • Women59%
  • Men39%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mark I. Grijnsztein wrote 819 Medicare Part D claims in 2024

In 2024, Dr. Grijnsztein wrote 819 Medicare Part D claims for 181 patients. 55% of them were for generic drugs. CMS names the drug for 685 of them, across 22 drugs with 11 or more claims each, at $522,444 in total drug cost. In 2023, CMS named 732 claims across 21 drugs.

Part D claims, 2024819
Drugs named by CMS22
Total drug cost$522,444
Part D patients181

Dr. Grijnsztein's Part D claims by kind of drug, 2024

  • Generic453 claims55%
  • Brand-name366 claims45%

Dr. Grijnsztein's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Grijnsztein's Part D claims, 2024

  • Antibiotics3%27 of 819 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7322024: 6856%

Drugs named by CMS: 22 in 2024, 21 in 2023.

See all prescribing by Dr. Grijnsztein

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mark I. Grijnsztein offers telehealth to Medicare patients

Dr. Grijnsztein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grijnsztein as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find allergists and immunologists like Dr. Grijnsztein by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark I. Grijnsztein received $236 in industry payments from 2016 to 2023

CMS Open Payments shows 8 general payments to Dr. Grijnsztein from 7 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 69% of the total. Boston Scientific Corporation paid the most, $74.

General payments to Dr. Grijnsztein by program year, 2016 to 2023

General payments to Dr. Grijnsztein by kind, 2016 to 2023

$236in total
  • Food and beverage$16269%
  • Education$7431%

Companies that paid Dr. Grijnsztein the most, 2016 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Grijnsztein

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mark I. Grijnsztein graduated from Tel Aviv University Sackler

Dr. Grijnsztein graduated from Tel Aviv University Sackler in 1998.

  1. Medical schoolTel Aviv University Sackler
  2. Board certified in allergy & immunologyAmerican Board of Allergy and Immunology

Source: Dmand AI Professional Profile Data

Dr. Mark I. Grijnsztein accepts plans from 13 insurance carriers

Dr. Grijnsztein is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Elevance
  • HCSC
  • Blue Cross Blue Shield of Massachusetts
  • Regence Health Plans
  • Alliant Health Plans
  • +5 more carriersWith a free account

Plan types Dr. Grijnsztein accepts, by number of carriers

  1. PPO9
  2. Medicare7
  3. HMO6
  4. EPO4
  5. POS3

Source: Dmand AI Insurance Network Data

Sources for Dr. Mark I. Grijnsztein's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark I. Grijnsztein

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark I. Grijnsztein's NPI number?

Dr. Mark I. Grijnsztein's NPI number is 1164580866. It was assigned on December 5, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark I. Grijnsztein?

Dr. Mark I. Grijnsztein is an allergist and immunologist in Elk Grove, California. The primary specialty in the NPI Registry is Allergy & Immunology Physician (taxonomy code 207K00000X).

Where does Dr. Mark I. Grijnsztein practice?

Dr. Grijnsztein practices at 8170 Laguna Blvd. Suite 112, Elk Grove, CA 95758. Dr. Grijnsztein's primary practice is Sutter Imaging Elk Grove in Elk Grove, California. Dmand AI also links Dr. Grijnsztein to 1 group practice or clinic.

What is Dr. Mark I. Grijnsztein's office phone number?

The practice phone on file for Dr. Grijnsztein is (916) 691-5922.

What is Dr. Mark I. Grijnsztein's medical license number?

Dr. Grijnsztein holds California license A96813, one of the licenses on file in 3 states.

Which states has Dr. Mark I. Grijnsztein been licensed in?

Dmand AI has state licenses on file for Dr. Grijnsztein in California (2006 to 2026), New Jersey (2004 to 2007) and New York (2001 to 2006).

Which hospitals is Dr. Mark I. Grijnsztein affiliated with?

Dr. Grijnsztein is affiliated with Sutter Medical Center, Sacramento.

What medical group is Dr. Mark I. Grijnsztein part of?

Dr. Grijnsztein is linked to SGMF Radiology.

Does Dr. Mark I. Grijnsztein accept Medicare?

Yes. CMS data shows Dr. Grijnsztein billed Medicare for 2,502 services in 2024, and Dr. Grijnsztein accepts Medicare assignment.

Does Dr. Mark I. Grijnsztein offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Grijnsztein as offering telehealth services.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Mark I. Grijnsztein see?

CMS counts 143 Medicare patients who saw Dr. Grijnsztein in 2024, with an average age of 72.

Is Dr. Mark I. Grijnsztein board certified?

Yes. Dr. Grijnsztein is board certified in allergy & immunology by the American Board of Allergy and Immunology.

What services does Dr. Mark I. Grijnsztein bill to Medicare?

In 2024, Dr. Grijnsztein's most billed Medicare services were allergy test or treatment (95004), allergy test or treatment (95165) and allergy test or treatment (95117).

Where did Dr. Mark I. Grijnsztein go to medical school?

Dr. Grijnsztein graduated from Tel Aviv University Sackler in 1998.

What drugs does Dr. Mark I. Grijnsztein prescribe most?

In 2024 Medicare Part D data, Dr. Grijnsztein's most prescribed drugs by claims were Ipratropium Bromide, Trelegy Ellipta and Dupixent Syringe.

Has Dr. Mark I. Grijnsztein received payments from drug or device companies?

CMS Open Payments shows $236 in general payments to Dr. Grijnsztein from 7 companies from 2016 to 2023. The largest total came from Boston Scientific Corporation.

How long has Dr. Mark I. Grijnsztein been practicing?

Dr. Grijnsztein graduated from medical school in 1998, 28 years ago.

What insurance does Dr. Mark I. Grijnsztein accept?

Dr. Grijnsztein is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to allergy and immunology practices?

See allergists and immunologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)